Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Ruiz

Showing results (351-360 of 376) with videos related to

Pageof 38
Sort By:
Cell Reports|June 12, 2026
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancerAnkita Shrivastava, Eric Nels Pederson, Trang Uyen Nguyen, et al.
Psychological Services|January 24, 2020
The Citizen Psychologist Curriculum-Preparing psychologists for public service: The 2018 American Psychological Association Presidential InitiativeJessica Henderson Daniel, Ronald H Rozensky, Catherine L Grus, et al.
Molecular and Cellular Biology|December 25, 2013
DREAM controls the on/off switch of specific activity-dependent transcription pathwaysBritt Mellström, Ignasi Sahún, Ana Ruiz-Nuño, et al.
Cancers|August 19, 2020
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET StudyRuth Vera, María Luisa Gómez, Juan Ramón Ayuso, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2022
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 studyMarta Español-Rego, Carlos Fernández-Martos, Elena Elez, et al.
Nature Cell Biology|June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Cancers|September 28, 2021
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS StudyPilar García-Alfonso, Andrés Muñoz, Jerónimo Jiménez-Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 1, 2026
Proton therapy in Spain: SEOR-SPROMP multidisciplinary recommendations developed through a RAND/UCLA consensus processAntonio José Conde-Moreno, Felipe Ángel Calvo Manuel, Patricia Diezhandino García, et al.
British Journal of Cancer|December 23, 2021
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trialElena Élez, María Auxiliadora Gómez-España, Cristina Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registryCarlos López-López, Eva Martínez de Castro, Ana Fernández Montes, et al.
Pageof 38

Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
Cell Reports|June 12, 2026
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancerAnkita Shrivastava, Eric Nels Pederson, Trang Uyen Nguyen, et al.
Psychological Services|January 24, 2020
The Citizen Psychologist Curriculum-Preparing psychologists for public service: The 2018 American Psychological Association Presidential InitiativeJessica Henderson Daniel, Ronald H Rozensky, Catherine L Grus, et al.
Molecular and Cellular Biology|December 25, 2013
DREAM controls the on/off switch of specific activity-dependent transcription pathwaysBritt Mellström, Ignasi Sahún, Ana Ruiz-Nuño, et al.
Cancers|August 19, 2020
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET StudyRuth Vera, María Luisa Gómez, Juan Ramón Ayuso, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2022
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 studyMarta Español-Rego, Carlos Fernández-Martos, Elena Elez, et al.
Nature Cell Biology|June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Cancers|September 28, 2021
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS StudyPilar García-Alfonso, Andrés Muñoz, Jerónimo Jiménez-Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 1, 2026
Proton therapy in Spain: SEOR-SPROMP multidisciplinary recommendations developed through a RAND/UCLA consensus processAntonio José Conde-Moreno, Felipe Ángel Calvo Manuel, Patricia Diezhandino García, et al.
British Journal of Cancer|December 23, 2021
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trialElena Élez, María Auxiliadora Gómez-España, Cristina Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registryCarlos López-López, Eva Martínez de Castro, Ana Fernández Montes, et al.
Pageof 38